Insurance help with clinical trial?

Posted by markymarkfl @markymarkfl, Apr 26 8:30am

I have access to a promising clinical trial that will require 3 weeks as a hospital in-patient.

Hospital is providing the drugs for free, but not the hospital stay, which they expect insurance to cover,

Insurance is balking because the therapy is not FDA approved, which is the point of trials, but I digress…

I’m developing some drug resistance and excess neuropathy on my second line of SoC chemo, and have about exhausted the FDA-approved menu of drugs for pancreatic cancer.

Any advice or resources for help getting coverage for this? Business is slow at my lemonade stand. 😉

Many thanks!!!

Interested in more discussions like this? Go to the Cancer Support Group.

Perhaps the physician head of the clinical trial can write to your insurance company to get the insurance company and Medicare on board and/or you file a letter consumer complaint with your state department of insurance and/or you send a letter to your Senator and Representative in Washington and finally, you hire a lawyer. Good luck. You should not have burden on top of your health burdens but it is not uncommon

REPLY

Contact the Study coordinators and the hospital's social workers, they are often able to find the funds to take care of your inpatient hospital expenses.

REPLY

I'm surprised they're able to recruit anyone to this trial under those conditions.

While you're obviously hoping that this trial will benefit you, from another perspective, this is mostly an experiment, which presumably will primarily benefit a pharmaceutical/ biotech company. It is not the insurance company's job to subsidize a drug company's research by paying for three weeks of hospitalization. As a tax-payer, I can't say I'm in favor of Medicare paying for this either.

The study coordinator seems like the person who should sort out this problem.

REPLY
@val64

I'm surprised they're able to recruit anyone to this trial under those conditions.

While you're obviously hoping that this trial will benefit you, from another perspective, this is mostly an experiment, which presumably will primarily benefit a pharmaceutical/ biotech company. It is not the insurance company's job to subsidize a drug company's research by paying for three weeks of hospitalization. As a tax-payer, I can't say I'm in favor of Medicare paying for this either.

The study coordinator seems like the person who should sort out this problem.

Jump to this post

.. many clinical trials have built-in funds to underwrite such expenses, either inpatient or outpatient.

REPLY
@vickyhay

.. many clinical trials have built-in funds to underwrite such expenses, either inpatient or outpatient.

Jump to this post

That's right. Either the drug company pays for it, or they get a grant from the NIH or a foundation. They shouldn't be trying to charge it to the patient's insurance.

REPLY

I thought when Trump was President he signed a bill that Insurance should cover trial treatments. I know he signed one but hope what I'm saying is accurate, BUT with this adminstration wonder if it is enforced. Worth checking out but I remember him stating this.

REPLY

As far as I know, the only thing related to this signed by Trump is the "right to try" law. This makes it somewhat easier to access unapproved treatments outside of clinical trials. But I don't think insurance has to pay for them. It seems like it would be a real mess if they did.

The ACA (Obamacare) requires insurance companies to pay for routine care of patients in clinical trials, ie any services that they would need anyway if they weren't in a clinical trial. But the three week in-patient stay doesn't seem to qualify on that count.

REPLY

Their claim that they can't cover because the treatment protocol is not yet FDA approved defeats the purpose of research (which you already know of course).

@markymarkfl, any update? Were you able to get the Principle Investigator or Study Coordinator to work with your insurance company to get the hospital stay covered?

REPLY

I'll believe it when I'm actually getting the treatment for real, but there was progress at the end of last week.

Part of the hiccup is that the treatment was developed by the research arm of a non-profit hospital system rather than a big pharmaceutical company with deep pockets. The drug is expensive but provided by the hospital. Of course the hospital's pockets are not exactly shallow, and they have some flexibility in what they can charge for room rates, but it got more complicated.

When I saw the hospital's public charge list, the rates for room and board varied from cheapest for Medicare patients, to medium for my insurance provider, to exorbitant for some lesser insurance companies. After I offered to self-pay for the room and board at a median rate, my insurance company clarified they wouldn't be paying for _any_ of the other testing or fees associated with the trial at all because it was experimental/investigational, although they have good results from this treatment with other types of cancer. That put it out of reach, temporarily...

BTW, a 3-week in-patient stay does seem to be the norm (or least not uncommon) for this type of therapy -- lymphodepletion followed by a stem cell transplant.

It would normally have gone from just a staring contest between the hospital and the insurance company to a "peer-to-peer" phone call between the treating oncologist (study lead) and the insurance company's medical director, but that was denied because coverage was "contractually excluded" by my policy.

So we started the standard, painful, multi-level appeal/grievance process before a Nurse Navigator / Advocate at the insurance company finally stepped in and arranged a peer-to-peer call to discuss "medical necessity" which cleared it up and got me the approval, since I've pretty much exhausted the Standard of Care treatments.

I'm fortunate that my huge employer has a cancer concierge program associated with their insurance; I think that carried some weight.

It's ironic that a social worker suggested last year that I retire early (age 60/61), claim disability and get on Medicare early. Aside from the facts that I'm not really too disabled to work (yet) and I (kind of) enjoy my job, I had heard enough bad things about Medicare that I've been reluctant to go that route.

The trial's research nurse told me none of the other patients on this study had been denied coverage by their insurance company, but that's only 4 people so far -- and most of them are on Medicare. I'll be patient #5 for the therapy overall, and patient #2 in the pancreatic cancer cohort.

My (private, employer-based insurance company's) nurse navigator told me Medicare doesn't generally seek pre-authorization for treatment; rather, it's sort of an honor system in which the government implicitly trusts providers up front but holds them accountable if the treatment is obviously frivolous, unnecessary, inappropriate, or whatever.

I understand the public distaste for programs that "socialize the risk but privatize the profits." Of course nobody wants to see money wasted, but research isn't free. Even the non-profit research centers have to pay big dollars for their top-notch PhD/MD researchers. That money doesn't grow on trees, but the government has made some funding available for cutting-edge research through the "Cancer Moonshot" program.

Anyway, it seems most of the bad things I've heard about Medicare are usually tied to the private "Medicare Advantage" plans.

I'll hold my comments about how messed up the system is (and how stressful it is to deal with) for now, and just thank God, my nurse navigator, and my oncologist for making this happen. I've volunteered since the day of my diagnosis 2.5 years ago to be a guinea pig for research. This is the first success getting into a clinical trial out of 6 I've applied for, and it's been 6 months in the making for this one. I sure hope it works!!!

REPLY
@markymarkfl

I'll believe it when I'm actually getting the treatment for real, but there was progress at the end of last week.

Part of the hiccup is that the treatment was developed by the research arm of a non-profit hospital system rather than a big pharmaceutical company with deep pockets. The drug is expensive but provided by the hospital. Of course the hospital's pockets are not exactly shallow, and they have some flexibility in what they can charge for room rates, but it got more complicated.

When I saw the hospital's public charge list, the rates for room and board varied from cheapest for Medicare patients, to medium for my insurance provider, to exorbitant for some lesser insurance companies. After I offered to self-pay for the room and board at a median rate, my insurance company clarified they wouldn't be paying for _any_ of the other testing or fees associated with the trial at all because it was experimental/investigational, although they have good results from this treatment with other types of cancer. That put it out of reach, temporarily...

BTW, a 3-week in-patient stay does seem to be the norm (or least not uncommon) for this type of therapy -- lymphodepletion followed by a stem cell transplant.

It would normally have gone from just a staring contest between the hospital and the insurance company to a "peer-to-peer" phone call between the treating oncologist (study lead) and the insurance company's medical director, but that was denied because coverage was "contractually excluded" by my policy.

So we started the standard, painful, multi-level appeal/grievance process before a Nurse Navigator / Advocate at the insurance company finally stepped in and arranged a peer-to-peer call to discuss "medical necessity" which cleared it up and got me the approval, since I've pretty much exhausted the Standard of Care treatments.

I'm fortunate that my huge employer has a cancer concierge program associated with their insurance; I think that carried some weight.

It's ironic that a social worker suggested last year that I retire early (age 60/61), claim disability and get on Medicare early. Aside from the facts that I'm not really too disabled to work (yet) and I (kind of) enjoy my job, I had heard enough bad things about Medicare that I've been reluctant to go that route.

The trial's research nurse told me none of the other patients on this study had been denied coverage by their insurance company, but that's only 4 people so far -- and most of them are on Medicare. I'll be patient #5 for the therapy overall, and patient #2 in the pancreatic cancer cohort.

My (private, employer-based insurance company's) nurse navigator told me Medicare doesn't generally seek pre-authorization for treatment; rather, it's sort of an honor system in which the government implicitly trusts providers up front but holds them accountable if the treatment is obviously frivolous, unnecessary, inappropriate, or whatever.

I understand the public distaste for programs that "socialize the risk but privatize the profits." Of course nobody wants to see money wasted, but research isn't free. Even the non-profit research centers have to pay big dollars for their top-notch PhD/MD researchers. That money doesn't grow on trees, but the government has made some funding available for cutting-edge research through the "Cancer Moonshot" program.

Anyway, it seems most of the bad things I've heard about Medicare are usually tied to the private "Medicare Advantage" plans.

I'll hold my comments about how messed up the system is (and how stressful it is to deal with) for now, and just thank God, my nurse navigator, and my oncologist for making this happen. I've volunteered since the day of my diagnosis 2.5 years ago to be a guinea pig for research. This is the first success getting into a clinical trial out of 6 I've applied for, and it's been 6 months in the making for this one. I sure hope it works!!!

Jump to this post

Sorry to hear about the difficulties you have been having with largely administrative issues when ideally you should be using all your time and energy to get better. Hopefully most of the red tape is now behind you. Take care and best wishes.

REPLY
Please sign in or register to post a reply.